0001225208-15-020421.txt : 20151109
0001225208-15-020421.hdr.sgml : 20151109
20151105120243
ACCESSION NUMBER: 0001225208-15-020421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151104
FILED AS OF DATE: 20151105
DATE AS OF CHANGE: 20151105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 GORDON DR
STREET 2: P O BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
STREET 2: PO BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malone Daniel
CENTRAL INDEX KEY: 0001527326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 151199553
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
CITY: LIONVILLE
STATE: PA
ZIP: 19341
4
1
doc4.xml
X0306
4
2015-11-04
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001527326
Malone Daniel
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
1
Vice President & Controller
Common Stock
2015-11-04
4
M
0
4456.0000
17.2250
A
27082.8536
D
Common Stock
2015-11-04
4
S
0
4456.0000
61.6500
D
22626.8536
D
Stock Option (Right to Buy)
17.2250
2015-11-04
4
M
0
4456.0000
17.2275
D
2007-06-22
2016-06-22
Common Stock
4456.0000
0.0000
D
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $61.58 to $61.69, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
Joanne K. Boyle as Agent for Daniel Malone
2015-11-05